China Money Network
Login
Join

Chinese VC Firm Decheng Capital Backs $14M Series A Round Of Biotech Start-Up

  • May 16, 2019 — 15:45 CST

This Data Is Locked!

This area is available only to Subscribers.

Chinese biotechnology start-up AnHeart Therapeutics announced on Wednesday that it has raised approximately RMB100 million (US$14.54 million) in a series A round of financing from... [DATA LOCKED]

UNLOCK DATA

Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals

Join

Access Thousands of Data Points to Monitor Chinese Private Equity Deal Movement and Relationships

Already Have an Account?

Login
Related Topics:

Related Data: